446 related articles for article (PubMed ID: 11276011)
1. Localized and systemic scleroderma show different histological responses to methotrexate therapy.
Seyger MM; van den Hoogen FH; van Vlijmen-Willems IM; van de Kerkhof PC; de Jong EM
J Pathol; 2001 Apr; 193(4):511-6. PubMed ID: 11276011
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children.
Weibel L; Sampaio MC; Visentin MT; Howell KJ; Woo P; Harper JI
Br J Dermatol; 2006 Nov; 155(5):1013-20. PubMed ID: 17034534
[TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma.
Pope JE; Bellamy N; Seibold JR; Baron M; Ellman M; Carette S; Smith CD; Chalmers IM; Hong P; O'Hanlon D; Kaminska E; Markland J; Sibley J; Catoggio L; Furst DE
Arthritis Rheum; 2001 Jun; 44(6):1351-8. PubMed ID: 11407694
[TBL] [Abstract][Full Text] [Related]
4. The changes in expression of ICAM-3, Ki-67, PCNA, and CD31 in psoriatic lesions before and after methotrexate treatment.
Yazici AC; Tursen U; Apa DD; Ikizoglu G; Api H; Baz K; Tasdelen B
Arch Dermatol Res; 2005 Dec; 297(6):249-55. PubMed ID: 16215763
[TBL] [Abstract][Full Text] [Related]
5. Treatment of pediatric localized scleroderma with methotrexate.
Fitch PG; Rettig P; Burnham JM; Finkel TH; Yan AC; Akin E; Cron RQ
J Rheumatol; 2006 Mar; 33(3):609-14. PubMed ID: 16511930
[TBL] [Abstract][Full Text] [Related]
6. [Scleroderma in children].
Frati Munari AC; Culebro Nieves G; Velázquez E; Podoswa G
Bol Med Hosp Infant Mex; 1979; 36(2):201-14. PubMed ID: 758191
[TBL] [Abstract][Full Text] [Related]
7. [Madecassol treatment of systemic and localized scleroderma].
Guseva NG; Starovoĭtova MN; Mach ES
Ter Arkh; 1998; 70(5):58-61. PubMed ID: 9644746
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study.
Kroft EB; Creemers MC; van den Hoogen FH; Boezeman JB; de Jong EM
Br J Dermatol; 2009 May; 160(5):1075-82. PubMed ID: 19210503
[TBL] [Abstract][Full Text] [Related]
9. Mast cell numbers in diffuse scleroderma.
Nishioka K; Kobayashi Y; Katayama I; Takijiri C
Arch Dermatol; 1987 Feb; 123(2):205-8. PubMed ID: 3813593
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of oral methotrexate in the treatment of systemic sclerosis.
Krishna Sumanth M; Sharma VK; Khaitan BK; Kapoor A; Tejasvi T
Int J Dermatol; 2007 Feb; 46(2):218-23. PubMed ID: 17269983
[TBL] [Abstract][Full Text] [Related]
11. Bullous morphoea: a retrospective study.
Venturi M; Pinna AL; Pilloni L; Atzori L; Ferreli C; Rongioletti F
Clin Exp Dermatol; 2017 Jul; 42(5):532-535. PubMed ID: 28543394
[TBL] [Abstract][Full Text] [Related]
12. [Linear scleroderma in children (apropos of 27 cases)].
Larrègue M; Ziegler JE; Lauret P; Bonafe J; Lorette G; Titi A; Ramdenee P; Bressieux JM
Ann Dermatol Venereol; 1986; 113(3):207-24. PubMed ID: 3752860
[TBL] [Abstract][Full Text] [Related]
13. Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma.
Yamamoto T; Nishioka K
Clin Immunol; 2002 Jan; 102(1):77-83. PubMed ID: 11781070
[TBL] [Abstract][Full Text] [Related]
14. Clinical appearance of skin lesions and disturbances of pigmentation in localized scleroderma.
Serup J
Acta Derm Venereol; 1984; 64(6):485-92. PubMed ID: 6084919
[TBL] [Abstract][Full Text] [Related]
15. Low-dose UVA1 phototherapy for proximal and acral scleroderma in systemic sclerosis.
Rose RF; Turner D; Goodfield MJ; Goulden V
Photodermatol Photoimmunol Photomed; 2009 Jun; 25(3):153-5. PubMed ID: 19438995
[TBL] [Abstract][Full Text] [Related]
16. [Histomorphologic and histochemical changes in the skin during the treatment of scleroderma].
Sych LI; Trofimova LIa
Vestn Dermatol Venerol; 1971; 45(3):22-6. PubMed ID: 5122538
[No Abstract] [Full Text] [Related]
17. Generalized morphea: a case report.
Payapvipapong K; Aunhachoke K
J Med Assoc Thai; 2010 Nov; 93 Suppl 6():S215-7. PubMed ID: 21280538
[TBL] [Abstract][Full Text] [Related]
18. [Systemic sclerosis (scleroderma) without scleroderma].
Nadashkevych ON
Lik Sprava; 2001; (3):93-4. PubMed ID: 11560041
[TBL] [Abstract][Full Text] [Related]
19. [Morphological changes in the skin in scleroderma in the process of treatment with unithiol].
Dubinskiĭ AA; Tseraidis GS; Guĭda PP; Petrusenko EA; Babykina EA
Vrach Delo; 1978 Oct; (10):112-4. PubMed ID: 716343
[No Abstract] [Full Text] [Related]
20. Methotrexate for sclerotic skin disorders: no evidence for effectiveness.
Jessop S; Whitelaw D
Br J Dermatol; 2009 Nov; 161(5):1205. PubMed ID: 19663873
[No Abstract] [Full Text] [Related]
[Next] [New Search]
